D-Mannose

Global D-Mannose Market to Reach US$1.1 Billion by 2030

The global market for D-Mannose estimated at US$861.3 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Capsule, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$592.9 Million by the end of the analysis period. Growth in the Tablet segment is estimated at 3.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$230.6 Million While China is Forecast to Grow at 5.9% CAGR

The D-Mannose market in the U.S. is estimated at US$230.6 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$218.4 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global D-Mannose Market - Key Trends & Drivers Summarized

Why Is D-Mannose Gaining Popularity as a Health Supplement?

D-Mannose, a naturally occurring sugar, has seen rising demand in the health and wellness market, particularly as a supplement for managing urinary tract infections (UTIs). Unlike antibiotics, which can have side effects and lead to antibiotic resistance, D-Mannose is a safer alternative that works by preventing bacteria from adhering to the walls of the urinary tract. The growing awareness of the benefits of natural and non-prescription treatments has contributed to the popularity of D-Mannose among health-conscious consumers. It is frequently recommended as a preventive solution, especially for individuals with recurrent UTIs. With an increasing preference for natural and functional health products, D-Mannose is becoming a staple in the dietary supplement market.

How Are Scientific Studies Supporting the Growth of the D-Mannose Market?

The scientific validation of D-Mannose’s efficacy in preventing UTIs has played a significant role in the expansion of its market. Clinical studies have demonstrated that D-Mannose can significantly reduce the incidence of recurrent UTIs without the adverse effects associated with long-term antibiotic use. These findings have led healthcare professionals and naturopaths to recommend D-Mannose as a preventive measure or supplementary treatment for urinary health. Furthermore, research exploring its additional benefits, such as improving gut health and supporting overall immune function, is expanding its application scope beyond urinary care. This scientific backing not only boosts consumer confidence but also attracts investment and innovation in the development of D-Mannose products, including powders, capsules, and beverages.

Where Are D-Mannose Products Being Utilized and Sold?

D-Mannose products are primarily sold through health stores, pharmacies, and online retail platforms specializing in dietary supplements. The convenience of e-commerce has allowed consumers to access D-Mannose products easily, contributing to its widespread availability and use. Apart from standalone supplements, D-Mannose is also incorporated into combination products that address urinary health, such as cranberry supplements and probiotics. This multifunctional approach appeals to consumers seeking comprehensive wellness solutions. Additionally, healthcare professionals and clinics focusing on natural medicine and women’s health often recommend and distribute D-Mannose, increasing its penetration into medical and wellness practices. The growth in demand is not limited to developed markets; emerging economies are also witnessing increased adoption as awareness of natural and preventive healthcare options rises.

What Factors Are Driving the Growth of the D-Mannose Market?

The growth in the D-Mannose market is driven by several factors, including the increasing preference for natural health products, rising consumer awareness about urinary health, and scientific research validating its benefits. The trend towards self-care and preventive health management has led consumers to seek non-pharmaceutical alternatives, boosting D-Mannose sales as a trusted and effective option. The rise of e-commerce platforms has further facilitated access to these products, making them available to a global audience. In addition, the focus on women’s health and the emphasis on solutions for recurrent UTIs have propelled the demand for D-Mannose. Innovation in product formulations, such as incorporating D-Mannose with probiotics or other natural ingredients, also contributes to market growth by appealing to health-conscious consumers seeking holistic and multifunctional supplements.

SCOPE OF STUDY:

The report analyzes the D-Mannose market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Capsule, Tablet, Powder); Application (Dietary Supplements, Functional Food, Pharmaceuticals, Animal Feed, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

• Atrium Innovations, Inc.
• Biotech Pharmacal, Inc.
• Dow, Inc.
• DuPont de Nemours, Inc.
• Hanseler AG
• Jarrow Formulas, Inc.
• Kyowa Hakko Kirin Co., Ltd.
• Now Health Group, Inc.
• Nutraceutical Corporation
• Pfanstiehl, Inc.
• VWR International LLC

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.